Biktarvy and Hypertriglyceridaemia - a phase IV clinical study of FDA data

Summary:

Hypertriglyceridaemia is reported as a side effect among people who take Biktarvy (bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate), especially for people who are male, 40-49 old, have been taking the drug for 1 - 6 months also take Truvada, and have Depression.

The phase IV clinical study analyzes which people have Hypertriglyceridaemia when taking Biktarvy. It is created by eHealthMe based on reports of 19,474 people who have side effects when taking Biktarvy from the FDA, and is updated regularly.

What is Biktarvy?

Biktarvy has active ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 19,543 Biktarvy users. Check the latest studies of Biktarvy.

What is Hypertriglyceridaemia?

Hypertriglyceridaemia (excess of triglycerides in the blood) is found to be associated with 755 drugs and 763 conditions by eHealthMe. Check the latest studies of Hypertriglyceridaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

19,474 people reported to have side effects when taking Biktarvy.
Among them, 15 people (0.08%) have Hypertriglyceridaemia.

Could Biktarvy cause Hypertriglyceridaemia?

Among these 15 people:

How long have people been on Biktarvy when they have Hypertriglyceridaemia? *

What is the gender of people who have Hypertriglyceridaemia when taking Biktarvy? *

female: 7.14 %
male: 92.86 %

What is the age of people who have Hypertriglyceridaemia when taking Biktarvy? *

What are other drugs people take besides Biktarvy? *

What are other side effects people have besides Hypertriglyceridaemia? *

Acute Kidney Failure: 4 people, 26.67%
Amoebic Dysentery (dysentery caused primarily by the amoeba entamoeba histolytica): 4 people, 26.67%
High Blood Cholesterol: 4 people, 26.67%
Hepatic Function Abnormal: 4 people, 26.67%
Folliculitis (infection of hair root): 4 people, 26.67%
Dermal Cyst: 4 people, 26.67%
Weight Increased: 3 people, 20.00%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 2 people, 13.33%
Pain: 2 people, 13.33%
Osteoporosis (bones weak and more likely to break): 2 people, 13.33%

What are the existing conditions these people have? *

Folliculitis (infection of hair root): 4 people, 26.67%
Depression: 4 people, 26.67%
Asymptomatic Hiv Infection: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Biktarvy and have Hypertriglyceridaemia?

- Check whether Hypertriglyceridaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Biktarvy:

Biktarvy (19,543 reports)

Hypertriglyceridaemia treatments and more:

Hypertriglyceridaemia (13,032 reports)

How severe was Hypertriglyceridaemia and when was it recovered:

Hypertriglyceridaemia in Biktarvy

Expand to all the drugs that have ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate:

Hypertriglyceridaemia and drugs with ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Biktarvy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypertriglyceridaemia:

Hypertriglyceridaemia (755 drugs)

Browse all the conditions that are associated with Hypertriglyceridaemia:

Hypertriglyceridaemia (763 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate (the active ingredients of Biktarvy) and Biktarvy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.